[
  {
    "ts": "2025-12-19T13:30:02+00:00",
    "headline": "Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today",
    "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
    "url": "https://finance.yahoo.com/news/heres-much-1000-investment-keysight-133002594.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "112d61aa-d655-3f73-aae2-63320b1f99b4",
      "content": {
        "id": "112d61aa-d655-3f73-aae2-63320b1f99b4",
        "contentType": "STORY",
        "title": "Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today",
        "description": "",
        "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
        "pubDate": "2025-12-19T13:30:02Z",
        "displayTime": "2025-12-19T13:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uV6mPOIlsfK8Kl7nmlunJw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc4z8_.3guA7NR27rd8O3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-much-1000-investment-keysight-133002594.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-much-1000-investment-keysight-133002594.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KEYS"
            },
            {
              "symbol": "A"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T18:07:00+00:00",
    "headline": "Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing",
    "summary": "Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation Sequencing (dTMS) platform. The collaboration brings together Agilent's enrichment chemistries—SureSelect for genomic DNA and Avida for cell-free DNA—and WBL's proprietary Oxford Nanopore-based native-read workflow, expanding access to scalable targeted multi-omic analysis for RUO and",
    "url": "https://finance.yahoo.com/news/wasatch-biolabs-announces-co-marketing-180700273.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "6bfd43f2-6c91-3081-99b7-e5194ce3a452",
      "content": {
        "id": "6bfd43f2-6c91-3081-99b7-e5194ce3a452",
        "contentType": "STORY",
        "title": "Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing",
        "description": "",
        "summary": "Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation Sequencing (dTMS) platform. The collaboration brings together Agilent's enrichment chemistries—SureSelect for genomic DNA and Avida for cell-free DNA—and WBL's proprietary Oxford Nanopore-based native-read workflow, expanding access to scalable targeted multi-omic analysis for RUO and",
        "pubDate": "2025-12-19T18:07:00Z",
        "displayTime": "2025-12-19T18:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f2fe6e0ac6f0848ea1b9a546a861a29c",
          "originalWidth": 400,
          "originalHeight": 48,
          "caption": "Wasatch BioLabs Logo (PRNewsfoto/Wasatch BioLabs)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zEmYrXiEgNCm4Wa6bLUbdA--~B/aD00ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/f2fe6e0ac6f0848ea1b9a546a861a29c.cf.webp",
              "width": 400,
              "height": 48,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j5lnbbrptZY32LnXqltf2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2fe6e0ac6f0848ea1b9a546a861a29c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/wasatch-biolabs-announces-co-marketing-180700273.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wasatch-biolabs-announces-co-marketing-180700273.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "A"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]